SCN5A
SCN5A encodes the primary sodium channel responsible for the electrical upstroke of the heartbeat. Mutations in this gene can lead to dangerous heart rhythms such as Brugada syndrome or Long QT syndrome, making it a central gene in cardiac electrophysiology.
Key Takeaways
- •SCN5A is the primary gene responsible for the electrical "spark" of each heartbeat.
- •It encodes the Nav1.5 channel, which allows sodium into heart cells to trigger contraction.
- •Loss-of-function mutations cause Brugada syndrome, leading to slow and chaotic rhythms.
- •Gain-of-function mutations cause Long QT type 3, where the heart takes too long to reset.
Basic Information
- Gene Symbol
- SCN5A
- Full Name
- Sodium Voltage-Gated Channel Alpha Subunit 5
- Also Known As
- Nav1.5HB1HH1
- Location
- 3p22.2
- Protein Type
- Ion Channel
- Protein Family
- Voltage-gated sodium channel family
Related Isoforms
Key SNPs
A common susceptibility variant that significantly modulates the risk of Brugada syndrome in diverse populations.
Linked to variations in the PR interval and QRS duration, reflecting its impact on the speed of electrical conduction.
A common polymorphism that acts as a genetic modifier that can rescue or worsen the effects of other primary mutations.
Located in the HEY2 locus; influences the expression level of SCN5A and is a major contributor to arrhythmic risk.
Associated with altered channel gating and susceptibility to atrial fibrillation.
Overview
The SCN5A gene provides instructions for making the Nav1.5 protein, a voltage-gated sodium channel that acts as the "ignition switch" for each heartbeat. When this channel opens, it allows a flood of positively charged sodium ions into the heart muscle cells, creating the rapid electrical impulse (Phase 0 of the action potential) that tells the heart to contract in a coordinated fashion.
Because electrical timing is critical for heart function, SCN5A must operate with millisecond precision. Even tiny changes in the speed at which the channel opens, stays open, or closes can have catastrophic consequences. This gene is the primary target of investigation for many forms of inherited arrhythmia and sudden cardiac death in young, otherwise healthy individuals.
Conceptual Model
A simplified mental model for the pathway:
Intentionally simplified; the channel’s behavior is modified by temperature, pH, and hundreds of regulatory proteins.
Core Health Impacts
- • Conduction spark: Primary engine of the heart's electrical conduction system.
- • Rhythm speed: Determines the speed and coordination of the heartbeat.
- • Arrhythmia defense: Protects against the development of lethal ventricular arrhythmias.
- • Pacemaker function: Essential for the proper functioning of the sinoatrial node.
- • Electrical excitability: Maintains electrical excitability in the atria and ventricles.
- • Drug targeting: Serves as a major drug target for anti-arrhythmic medications.
Protein Domains
Pore Domain
The selective filter that allows only sodium ions to pass through while blocking other ions like potassium.
Voltage Sensor
Charged regions that detect changes in membrane voltage and trigger the opening of the channel.
Inactivation Gate
The molecular "ball and chain" that swings shut to stop the sodium flow and allow the heart to reset.
Upstream Regulators
TBX5 Activator
A master cardiac transcription factor that drives the high-level expression of SCN5A.
NKX2-5 Activator
Essential for the proper developmental patterning of the heart and sodium channel maintenance.
GATA4 Activator
Works in coordination with TBX5 to bind the SCN5A promoter.
SGK1 Activator
A kinase that prevents the degradation of Nav1.5 channels by the Nedd4-2 ligase.
MZF1 Activator
A specific transcriptional activator that targets the SCN5A promoter in cardiomyocytes.
PITX2 Activator
Involved in setting atrial electrical properties and regulating sodium channel subunits.
Downstream Targets
Sodium Current (I_Na) Activates
The primary output; SCN5A generates the rapid inward current that triggers the action potential.
Cardiac Action Potential Activates
Specifically responsible for Phase 0 (the upstroke), the spark for every heartbeat.
Ankyrin-G Activates
A structural protein that anchors the Nav1.5 channel to the intercalated discs.
Syntrophin Activates
Helps stabilize the sodium channel at the cell membrane and coordinates cytoskeleton interaction.
Purkinje Fibers Activates
The rapid conduction system of the heart that relies on SCN5A-mediated currents.
Calmodulin Activates
Binds the C-terminus to regulate calcium-dependent inactivation.
Role in Aging
The heart's electrical system typically slows down with age. SCN5A is the primary protein that maintains the "electrical youth" of the cardiac conduction system.
Conduction Slowing
The expression and activity of SCN5A often decline with age, contributing to progressive conduction delay.
Fibrotic Barriers
As scar tissue builds up, the sodium current must work harder to overcome these electrical "dead zones."
Oxidative Insult
The Nav1.5 channel is sensitive to oxidative stress; age-related damage can lead to "leaky" channels.
Hormonal Waning
Declines in testosterone and insulin sensitivity can reduce functional sodium channels at the surface.
Atrial Fibrillation
Aging is the primary risk factor for AF; SCN5A dysfunction contributes to the sustaining electrical remodeling.
Sudden Death Risk
Age-related electrical instability can unmask latent SCN5A variants in later life.
Disorders & Diseases
Brugada Syndrome (BrS)
A loss-of-function condition where the sodium current is too weak. It often leads to sudden cardiac arrest during sleep or fever.
Long QT Syndrome Type 3
A gain-of-function condition where the channel fails to close properly, delaying the heart’s reset and risking Torsades de Pointes.
Sick Sinus Syndrome
Dysfunction of the heart’s natural pacemaker, leading to abnormally slow heart rates.
Lev-Lenègre Disease
A progressive disorder where the heart’s electrical wiring slowly fails, leading to heart blocks.
Arrhythmogenic Cardiomyopathy
Some mutations cause structural changes, including the weakening and enlargement of the heart muscle.
Interventions
Supplements
Crucial for maintaining electrical stability and supporting proper ion channel function.
May help stabilize cell membranes and reduce the risk of triggers for dangerous rhythms.
Deficiency is associated with increased arrhythmia risk and may influence cardiac gene expression.
Provides mitochondrial support for heart cells, essential for the energy required for ion pumping.
Maintaining a precise balance of sodium, potassium, and calcium is essential.
Lifestyle
Aggressive use of antipyretics is critical, as high body temperature is a major trigger for cardiac arrest.
Must strictly avoid medications listed on BrugadaDrugList.org (anesthetics, antidepressants).
Excessive alcohol intake can act as a trigger for arrhythmias in susceptible individuals.
Ensures stable electrolyte concentrations and blood volume to support electrical health.
Medicines
A sodium channel blocker used in LQT3 to reduce the dangerous "late" sodium current.
A specialized anti-arrhythmic that can prevent electrical storms in Brugada syndrome.
Emergency medication used to stabilize the heart rhythm during a Brugada crisis.
The definitive treatment for high-risk patients; monitors and shocks lethal rhythms.
Lab Tests & Biomarkers
Electrical Testing
Primary screening tool for Brugada patterns or QT prolongation.
Pharmacological stress test used to unmask a hidden Brugada pattern.
Detects subtle signs of delayed conduction in the ventricles.
Genetic Testing
Comprehensive analysis of the gene to find rare pathogenic mutations.
Emerging tool that sums common variants to predict disease severity.
Clinical Monitoring
A 24-48 hour recording of the heart rhythm to find transient arrhythmias.
Used to rule out structural heart diseases that can mimic SCN5A syndromes.
Hormonal Interactions
Testosterone Potent Modulator
Higher levels are strongly associated with the Brugada phenotype, explaining the male dominance.
Thyroid Hormone (T3) Metabolic Activator
Directly regulates heart rate and conduction speed; thyrotoxicosis lowers the threshold.
Insulin Trafficking Regulator
Signals through SGK1 to increase the number of Nav1.5 channels at the surface.
Cortisol Stress Regulator
Influences channel stability and the overall adrenergic tone of the system.
Estrogen Protective Modulator
Generally associated with a lower risk of Brugada syndrome but may influence the QT interval.
Aldosterone Electrolyte Regulator
Maintains the systemic sodium balance required for the SCN5A-mediated spark.
Deep Dive
Network Diagrams
The Sodium Current Spark (Phase 0)
Sodium Channel Trafficking & Stabilization
Biological Role: The Action Potential Spark
The Nav1.5 channel is responsible for Phase 0 of the cardiac action potential. When the channel opens, sodium rushes into the cell, rapidly changing the electrical charge across the cell membrane. This influx of millions of sodium ions in less than a millisecond is the “spark” that initiates the spread of electricity from one cell to the next.
This signal then travels through the heart’s conduction system to trigger a contraction. If SCN5A function is reduced, this wave moves too slowly, creating the “conduction delay” seen in Brugada syndrome. Conversely, if it “leaks” (gain-of-function), the cell remains electrically charged for too long, setting the stage for a chaotic second spark.
Intervention Relevance: Precision Arrhythmia Management
For high-risk individuals with SCN5A mutations, an implantable defibrillator (ICD) is the most effective way to prevent sudden death by delivering a life-saving electrical shock to reset a dangerous rhythm.
Beyond devices, lifestyle management is critical. Fever is a powerful trigger for arrhythmias in Brugada syndrome, making aggressive use of antipyretics mandatory. Patients must also strictly avoid certain medications (antidepressants, anesthetics) that can block already-weakened sodium channels. Pharmacologically, mexiletine is used in LQT3 to block the “late” sodium current, while quinidine can prevent “electrical storms” in Brugada syndrome.
Relevant Research Papers
Links go to PubMed (abstracts are public); some papers also offer free full text via PMC or the publisher.
Identified gain-of-function sodium channel mutations as a cause of sudden death.
Established loss-of-function sodium channel defects as the basis for Brugada syndrome.
Definitive review of the molecular architecture and regulatory sites of the Nav1.5 protein.
Showed how common genetic variants determine the severity of the disease.
Large-scale analysis of how different types of SCN5A mutations predict clinical outcomes.
Mechanistic details on how metabolic hormones control the density of sodium channels.